New York City, New York Jun 18, 2025 (Issuewire.com) - Sureka Bollepalli, MD, a board-certified endocrinologist and the CEO and Medical Director of Tampa Bay Medical Research, is making significant strides in the field of metabolic diseases, particularly focusing on type 2 diabetes and non-alcoholic steatohepatitis (NASH). With an unwavering commitment to advancing treatment options through research, education, and preventive care, Dr. Bollepallis career exemplifies the transformative power of medical innovation.
She began her academic journey at Emory University, where she earned a Bachelor of Science in Biology in 1998. Dr. Bollepallis early promise in biomedical sciences was recognized with an American Heart Association Fellowship Grant in 1997. She continued her education at St. Georges University School of Medicine, graduating with distinction in 2003 and earning induction into the Iota Epsilon Alpha Honor Society.
After obtaining ECFMG® certification, Dr. Bollepalli completed her pediatric residency and achieved board certifications in both General Pediatrics and Pediatric Endocrinology. She further specialized through a fellowship at Cincinnati Childrens Hospital Medical Center, solidifying her expertise in endocrinology by 2009.
During her remarkable 20-year tenure at the University of South Florida, Dr. Bollepalli served as an Assistant Professor in the Department of Pediatrics and the Diabetes and Endocrinology Center. She has been a prominent educator, delivering lectures on diabetes and obesity to a variety of audiences, including college students, nurses, and medical professionals. Her commitment to integrating education with clinical practice is a cornerstone of her career.
In her current role as CEO of Tampa Bay Medical Research, Dr. Bollepalli has been pivotal in all aspects of clinical study development, from protocol design to data analysis. Her leadership has garnered national attention, highlighted by the ACEND Award in 2021 for her exceptional performance as a new NASH investigator and multiple Peak Performer Awards in 2024 and 2025 for excellence in clinical study startup. Additionally, she was recognized in Best in Florida Magazine in both 2023 and 2025 and named one of Americas Top Pediatricians in 2014.
Beyond her impressive professional accomplishments, Dr. Bollepalli is dedicated to enhancing community health. Since 2020, she has spearheaded a community health initiative providing free fibroscans to identify and educate individuals at risk for NASH. Her passion for youth with diabetes is reflected in her volunteer work at Florida Diabetes Summer Camps and Sam Fuld Diabetes Sports Camps from 2013 to 2019.
Outside her professional commitments, Dr. Bollepalli is a passionate runner and an avid tennis player. She values quality time spent traveling with her husband and three children, balancing a dynamic career in medicine with a strong commitment to family wellness.
Dr. Bollepallis relentless pursuit of excellence in medical research and community health initiatives positions her as a leading figure in the field of endocrinology. Her dedication not only advances treatment options for patients but also fosters a healthier future for the Tampa Bay community.
Learn More about Dr. Sureka Bollepalli:
Through her findatopdoc profile, https://www.findatopdoc.com/doctor/410612-Sureka-Bollepalli-Endocronologist-Pediatric or through Tampa Bay Medical Research, https://tampabaymedicalresearch.com/our-team/#toggle-id-1
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
Source :Dr. Sureka Bollepalli
This article was originally published by IssueWire. Read the original article here.